| EMA number | EMEA/H/C/002633 |
| ATC code | J01GB01 |
| Authorisation | 18 March 2015 |
| Withdrawn | 18 February 2019 |
| Revision | 3 |
Vantobra is indicated for the management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients aged 6 years and older with cystic fibrosis (CF). Consideration should be given to official guidance on the appropriate use of antibacterial agents.